Publication | Open Access

Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53

Cervical CancerOncogenic AgentMedicineCervical Cancer CellsCell DeathMolecular BiologyRuthenium OligonucleotidesTumor SuppressorHpv16 E6 OncogeneCancer BiologyCell BiologyTumor BiologyCancer-associated Virus